Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.

Cencini, Emanuele; Fabbri, Alberto; Sicuranza, Anna; Santoni, Adele; Bocchia, Monica

Cencini, Emanuele; Fabbri, Alberto; Sicuranza, Anna; Santoni, Adele; Bocchia, Monica.

Affiliation

Cencini E; Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
Fabbri A; University of Siena, Siena, Italy.
Sicuranza A; Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
Santoni A; University of Siena, Siena, Italy.
Bocchia M; University of Siena, Siena, Italy.

Hematol Oncol ; 37(4): 493-495, 2019 Oct.

Article in En | MEDLINE | ID: mdl-31475736

Subject(s)

Hodgkin Disease/mortality; Hodgkin Disease/therapy; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Bleomycin/administration & dosage; Consolidation Chemotherapy; Dacarbazine/administration & dosage; Disease-Free Survival; Doxorubicin/administration & dosage; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Survival Rate; Vinblastine/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2019 Document type: Article

Fulltext

XML

PubMed Links

Search on Google